These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9473789)

  • 1. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.
    Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A
    Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index].
    Xu QZ; Liu F; Lu DH; Yu SZ; Yang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):341-5. PubMed ID: 12940073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.
    Ranuncolo SM; Varela M; Morandi A; Lastiri J; Christiansen S; Bal de Kier Joffé E; Pallotta MG; Puricelli L
    J Neurooncol; 2004 Jun; 68(2):113-21. PubMed ID: 15218947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study.
    Fels C; Schäfer C; Hüppe B; Bahn H; Heidecke V; Kramm CM; Lautenschläger C; Rainov NG
    J Neurooncol; 2000 Jul; 48(3):207-16. PubMed ID: 11100818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.
    Cunningham JM; Kimmel DW; Scheithauer BW; O'Fallon JR; Novotny PJ; Jenkins RB
    J Neurosurg; 1997 Jan; 86(1):121-30. PubMed ID: 8988090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome.
    Pescarmona E; Pignoloni P; Puopolo M; Martelli M; Addesso M; Guglielmi C; Baroni CD
    J Pathol; 2001 Oct; 195(3):361-6. PubMed ID: 11673835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in astrocytic gliomas and their correlation to cell proliferation.
    Dietzmann K; von Bossanyi P; Sallaba J; Kirches E; Synowitz HJ; Warich-Kirches M
    Gen Diagn Pathol; 1996 May; 141(5-6):339-44. PubMed ID: 8780933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors.
    Bian XW; Shi JQ; Liu FX
    Anal Quant Cytol Histol; 2000 Dec; 22(6):429-37. PubMed ID: 11147296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status.
    Newcomb EW; Bhalla SK; Parrish CL; Hayes RL; Cohen H; Miller DC
    Acta Neuropathol; 1997 Oct; 94(4):369-75. PubMed ID: 9341939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
    Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C
    Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
    Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
    Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis.
    Verstegen MJ; Leenstra DT; Ijlst-Keizers H; Bosch DA
    J Neurooncol; 2002 Jan; 56(1):21-8. PubMed ID: 11949823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
    Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
    Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 protein expression in grade II astrocytomas: immunohistochemical study of 100 cases with long-term follow-up.
    Vital A; Loiseau H; Kantor G; Daucourt V; Chene G; Cohadon F; Rougier A; Rivel J; Vital C
    Pathol Res Pract; 1998; 194(12):831-6. PubMed ID: 9894248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers relating to malignant progression in Grade II astrocytoma.
    Yue WY; Yu SH; Zhao SG; Chen ZP
    J Neurosurg; 2009 Apr; 110(4):709-14. PubMed ID: 19025355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Bcl-2, Bcl-x, and Bax proteins in astrocytomas in relation to patient survival.
    Daido S; Tamiya T; Ono Y; Terada K; Mizumatsu S; Ohmoto T
    Brain Tumor Pathol; 2001; 18(2):123-9. PubMed ID: 11908868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.